TGA rules out over-the-counter sales of oral contraceptives The RACGP has consistently opposed any efforts to down-schedule the pill, citing patient safety.
Guillain-Barré Syndrome deaths ‘likely linked’ to COVID vaccine An independent expert group has confirmed the two fatal cases are likely linked to AstraZeneca, but the complexity of the syndrome means uncertainties remain.
Vaccine myocarditis risk reaches 1 in 10,000 for adolescent boys But while the rate of Pfizer-related myocarditis continues to increase in males aged 12–17, research cited by the TGA indicates the risk is still dwarfed by the threat COVID-19 poses to this cohort.
Changes to medicinal cannabis prescribing pathways The changes will improve patient access and reduce the administrative burden on prescribers, according to the TGA.
Sixty new cases of myocarditis in TGA’s latest safety report The rare side effect has been more common in adolescent boys after receiving the second dose of mRNA vaccine.
GPs to take central role in vaccine booster rollout What will the new COVID-19 vaccine booster program mean for general practices around the country?
Contraceptive pill to remain prescription only – at least for now The TGA is not due to make a final ruling until later this year, but GPs fear the implications if the interim decision is overturned.
TGA monitoring overseas Moderna recommendations Several countries have limited the use of the mRNA vaccine in younger people, but there is no sign Australia will institute a similar pause.
Adolescents at most risk of developing myocarditis: TGA Myocarditis rates related to the Pfizer vaccine been released, while the Moderna vaccine has been included in the safety report for the first time.
One in a million chance of death following AstraZeneca jab: TGA By contrast, Australians aged 60 and over – for whom AstraZeneca is preferred – have a nearly one in 10 chance of dying from COVID.